News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avant Immunotherapeutics (AVAN) CEO to Present at the 28th Annual Canaccord Adams Global Growth Conference


8/9/2008 11:25:40 PM

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the 28th Annual Canaccord Adams Global Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 4:00 pm, EDT.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES